Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca - Business Wire

Owkin to Build AI Agents as Part of a Multi-Year K Pro License Agreement With AstraZeneca    Business Wire AstraZeneca pens agentic AI licensing deal with Owkin    Fierce Biotech AstraZeneca, Owkin to Develop AI Agents for Drug Discovery Decision-making    marketscreener.com Owkin Expands AstraZeneca Collaboration Around K Pro AI Platform    Yahoo Finance Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration    The Jerusalem Post

Original source: Google News